Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trials
European Heart Journal | December 14, 2017 | Volume: 39 | Issue: 23 | Pages: 2208-2216
10.1093/eurheartj/ehx764
| PMID 29315376